Development of immuno-monitoring methods and immunotherapy using glioma antigens
Development of immuno-monitoring methods and immunotherapy using glioma antigens
批准号:
15390444
负责人:
TODA Masahiro
金额:
$8.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
本研究通过对胶质瘤患者血清进行SEREX(重组表达克隆抗原的血清学鉴定)筛选人类睾丸cDNA文库,鉴定出胶质瘤抗原SOX6,一个与sry相关的HMG(高迁移率组)box-containing基因。36例胶质瘤患者中有12例(33.3%),14例其他脑部疾病患者中有0例(0%),54例其他癌症患者中有1例(1.9%)血清中检测到SOX6 IgG抗体。在37名健康人的血清中,除1名老年女性外,未检测到针对SOX6的IgG应答。此外,对胶质瘤患者血清的Western blot和ELISA分析显示,SOX6的dna结合结构域HMG盒可能是抗SOX6的igg的显性表位。RT-PCR和Northern blot分析显示,除了睾丸外,SOX6基因在胶质瘤组织中的表达高于正常成人组织。抗SOX6抗体免疫组化分析显示,所分析的胶质瘤组织在肿瘤细胞中均表达SOX6,而在大脑皮层非肿瘤组织中仅检测到少量SOX6阳性细胞。通过t细胞表位分析,我们鉴定了两个源自SOX6抗原的HLA-A24限制性肽。使用这些表位肽,我们证明可以诱导针对胶质瘤抗原SOX6的细胞毒性T细胞。综上所述,我们鉴定了一种胶质瘤抗原SOX6,并分析了SOX6的表达模式、抗原特异性和T细胞表位。
英文摘要
In this study, a human testis cDNA library was screened by SEREX (serological identification of antigens by recombinant expression cloning) with sera from glioma patients, we identified a glioma antigen, SOX6, an Sry-related HMG (high mobility group) box-containing gene. IgG antibodies against SOX6 were detected in sera from 12 of 36 glioma patients (33.3%), 0 of 14 patients with other brain disease (0%), and 1 of 54 other cancer patients (1.9%). In sera from 37 healthy individuals, no IgG responses against SOX6 were detected, except in an elderly female. Furthermore, Western blot and ELISA analyses with sera from glioma patients revealed that the DNA-binding domain, the HMG box of SOX6, might be a dominant epitope of IgGs against SOX6. RT-PCR and Northern blot analysis revealed that the SOX6 gene was more highly expressed in glioma tissues than in normal adult tissues, except testis. Immunohistochemical analysis with the anti-SOX6 antibody showed that all the glioma tissues analyzed expressed SOX6 in tumor cells, but only a few SOX6-positive cells were detected in nonneoplastic tissues from the cerebral cortex. By T-cell epitope analysis, we idendified two HLA-A24 restricted peptides derived from SOX6 antigen. Using these epitope peptides, we demonstrated to induce cytotoxic T cells specific for the glioma antigen, SOX6. In summary, we identified a glioma antigen, SOX6, and analyzed the expression pattern, antigen specificity, and T cell epitope of the SOX6.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2006
期刊:
Vaccines 26
影响因子:
--
作者:
[Kakizawa, S., Moriguchi, S., Ikeda, A. Iino, M. & Takeshima, H., Toda M]
通讯作者:
Toda M
DOI:
10.1002/jnr.20086
发表时间:
2004-05-15
期刊:
JOURNAL OF NEUROSCIENCE RESEARCH
影响因子:
4.2
作者:
[Mikami, Y, Okano, H, Toda, M]
通讯作者:
Toda, M
Augmentation of Antitumor Immune Responses by Multiple Intratumoral Inoculations of Replication-Conditional HSV and Interleukin-12.
通过多次瘤内接种复制条件 HSV 和 Interleukin-12 增强抗肿瘤免疫反应。
DOI:
--
发表时间:
2004
期刊:
J Immunother 27
影响因子:
--
作者:
[Iizuka Y, Kawakami Y, et al.]
通讯作者:
et al.
選択的複製型ヘルペスウイルスによる癌ワクチン療法の開発
利用选择性复制疱疹病毒开发癌症疫苗疗法
DOI:
--
发表时间:
2003
期刊:
がん治療のあゆみ
影响因子:
--
作者:
[清水啓介, 戸田正博, 高島 一, 児玉 亮, 森下竜一, 戸田正博, 戸田正博]
通讯作者:
戸田正博
Identification of human tumor antigens and its implication for diagnosis and treatment of cancer
人类肿瘤抗原的鉴定及其对癌症诊断和治疗的意义
DOI:
--
发表时间:
2004
期刊:
Cancer Sci 95・10
影响因子:
--
作者:
[Kawakami Y, Fujita T, Matsuzaki Y, Sakurai T, Tsukamoto M, Toda M, Sumimoto H]
通讯作者:
Sumimoto H
共 22 条
Immunotherapy targeting brain tumor stem cell antigen and niche
-
批准号:24659657
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:TODA Masahiro
-
依托单位:
Analysis of stemness regulators in brain cancer stem cells
-
批准号:22390283
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2010
-
负责人:TODA Masahiro
-
依托单位:
Development of immunotherapy targeting glioma and glioma stem cell antigens
-
批准号:19390384
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2007
-
负责人:TODA Masahiro
-
依托单位:
SALIVARY ASSESSMENT OF LIFESTYLE AND COMPREHENSIVE HEALTH STATUS
-
批准号:18590555
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.53万
-
财政年份:2006
-
负责人:TODA Masahiro
-
依托单位:
Identification of glioma specific genes for the molecular marker
-
批准号:13671465
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:TODA Masahiro
-
依托单位:
Identification of antigens specific for brain tumors
-
批准号:12557120
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:2000
-
负责人:TODA Masahiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
COSMC/Tn antigen/mTOR 轴调控胃癌细胞转移的分子机制
研究
-
批准号:2024JJ9400
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:赵娟霞
-
依托单位:
T细胞识别的鳞状细胞癌1型抗原增强干扰素-α抗丙型肝炎病毒作用的研究
-
批准号:81170386
-
项目类别:面上项目
-
资助金额:45.0万元
-
批准年份:2011
-
负责人:赵鸿
-
依托单位:
新的膀胱癌特异基因UCA1在膀胱癌高表达的分子机理
-
批准号:30801325
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:张争
-
依托单位:
基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
-
批准号:30771999
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2007
-
负责人:王立新
-
依托单位:
Shp2 在polyomavirus middle T antigen(mT)诱发肿瘤过程中的作用
-
批准号:30700392
-
项目类别:青年科学基金项目
-
资助金额:15.0万元
-
批准年份:2007
-
负责人:杨瑛
-
依托单位:
以Ag43为新型载体和佐剂的重组多价亚单位疫苗抗疟机理研究
-
批准号:30560160
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2005
-
负责人:谭光宏
-
依托单位:
Ag43/Fcε3嵌合细菌表面抗原蛋白疫苗抗I型变态反应研究
-
批准号:30460050
-
项目类别:地区科学基金项目
-
资助金额:19.0万元
-
批准年份:2004
-
负责人:谭光宏
-
依托单位: